Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

brexit_flag

83% in healthcare say UK will not be attractive for R&D and manufacturing post-Brexit

November 30, 2018 Medical Communications, Research and Development R&D, UK, brexit, pharma

As the Brexit crisis continues to spiral, new findings from GlobalData reveal that 83% of healthcare professionals in the UK …
News

Bayer announces major restructure, 12,000 jobs to go

November 30, 2018 Medical Communications, Sales and Marketing Bayer, job cuts, monsanto, pharma

Bayer has announced a major restructure of its operations in 2019 which will see the loss of 12,000 of its …
News

UK is among the first to meet UN targets for HIV treatment and prevention, Public Health England says

November 29, 2018 Medical Communications HIV, UK, pharma

The UK is among the first countries in the world to meet the HIV treatment targets set out by the …
News
shutterstock_204190579

UK cervical cancer screening rates fall to 21-year low

November 28, 2018 Medical Communications, Research and Development Cancer, NHS, UK, cervical cancer, pharma

A report by NHS Digital has revealed that cervical cancer screening coverage has fallen to 71.4%, down from 72% in …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 23, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kymriah, Mundipharma, UK, US, brexit, pharma, politics, top 10

The appointment of GSK veteran Arnaud Breabout to the position of Senior Vice President and CFO of Mundipharma took the …
News
novartis_window

Novartis’ gene therapy Luxturna becomes first approved European therapy for vision loss subtype

November 23, 2018 Medical Communications, Sales and Marketing EU, Europe, Luxturna, Novartis, pharma, vision loss

Novartis has revealed that its one-time gene therapy Luxturna (voretigene neparvovec) has been awarded approval by the European Commission to …
News

Immuno Biotech owner promoting unlicensed ‘cure’ for cancer, autism and HIV to be sentenced next week

November 23, 2018 Medical Communications Cancer, David Noakes, GcMAF, HIV, UKIP, autism

The owner of Guernsey-based biotech Immuno Biotech Ltd, David Noakes, will be sentenced this week after admitting to a number …
News

New report finds link between social media and poor mental health among young people

November 23, 2018 Medical Communications

Young people between the ages of 11 and 19, living with a mental disorder, were more likely to use social …
News
nhs_andrew_tatlow

NHS hospitals paying 167% more for drugs since 2010/11

November 23, 2018 Medical Communications Cost, NHS, UK, hospitals, pricing

Medicines are costing the NHS more than 50% more than a decade ago, while hospitals are paying more than twice …
News
ian_hudson

MHRA Chief to step down in 2019

November 21, 2018 Medical Communications, Research and Development MHRA, UK, brexit, pharma

The Medicines and Healthcare products Regulatory Agency (MHRA), the regulator responsible for the efficacy and safety of medicines in the …
News
arnaud_breabout

Mundipharma name GSK veteran as new Senior Vice President & CFO

November 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cambridge, Mundipharma, arnaud breabout, cfo, svp, wsenior vice president

The Mundipharma network today confirmed the appointment of Arnaud Breabout, to the position of Senior Vice President & Chief Financial …
Appointment
david_wehner

Alector strengthens board with three appointments including Facebook CFO David Wehner

November 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Facebook’s Chief Financial Officer (CFO) David Wehner has joined the board of San Francisco-based biotech Alector, a company that hopes …
Appointment
astrazeneca_sign_sky

AstraZeneca’s Imfinzi immunotherapy combo fails to show benefit in lung cancer

November 16, 2018 Medical Communications, Research and Development AstraZeneca, Cancer, Imfinzi, lung cancer, pharma

AstraZeneca has revealed that its immunotherapy combo of Imfinzi (durvalumab) and tremelimumab failed to meet its primary endpoint in a …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Korea, NICE, Samsung, Theresa May, UK, brexit, politics, top 10

The Samsung scandal played a prominent role in this weeks’ top ten after the South Korean firm was delisted from …
News
boehringer_biberach_germany_copy

Boehringer signs $300 million deal with Epizyme over epigenetic cancer treatment

November 16, 2018 Medical Communications Boehringer, Cancer, Epizyme, deal, oncology

German firm Boehringer Ingelheim and the Massachusetts-based biotech Epizyme have announced that they will collaborate on the development of novel, …
News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026